ASGHAR, K.; LOYA, A. INDOLEAMINE 2,3 DIOXYGENASE AS AN IMMUNOTHERAPEUTIC TARGET BRINGS A NEW HOPE FOR CANCER PATIENTS. Journal of Cancer & Allied Specialties, v. 4, n. 3, 30 Sep. 2018.